The following proposal is marked "normal" and as such will be in Phase 3 in Snapshot for 3 days. Votes will be taken into account if posted before 5:45am PT | 8:45am ET | 12:45pm GMT on Fri Aug 8 2025.

———

Quantum Biology DAO “Mid-Term Treasury Management” Proposal, v1.1

Quantum Biology DAO Development Proposal - 021 (QBIO DP-21)

Title: Quantum Biology DAO “Mid-Term Treasury Management” Proposal

Proposal text: https://docs.google.com/document/d/10GES8YsclLweTAzIpUI_W5HKiTQ3noestm8vZjQi3FQ/edit?tab=t.0.

Summary

This development proposal institutes a policy for the management of the Quantum Biology DAO treasury. It enumerates which trades and transfers are authorized, beyond those already authorized by previous proposals. It sets aside funds in USDC for DAO runway, including both DAO operations and previous DAO grants. It retains treasury assets in ETH and PAXG, which is a token pegged to gold, and makes provision for staking both USDC and ETH. It also replaces DP-17, which was the previous near-term treasury management proposal.

Background

In May 2025, the Quantum Biology DAO adopted a Near-Term Treasury Management plan (DP-17) to help it navigate during the recovery of ETH prices. That proposal specified that the DAO should retain the services of an external advisor to advise on treasury management and pass a Mid-Term Treasury Management plan within two months to supplement or replace the Near-Term Treasury Management plan.

During the intervening time, DAO Core Contributors and the leader of the DAO’s Treasury working group retained the services of an external advisor on treasury-related matters and met with them weekly. Through these meetings and discussions among themselves, the leader of the DAO’s Treasury working group created a plan that involved (1) maintaining six months of runway in a minimally risky stablecoin pegged to the US dollar, (2) leaving most of the DAO’s treasury in ETH to retain exposure to ETH’s positive upside, (3) using well-reputed staking services to earn staking rewards where possible, and (4) putting a small portion of the remaining DAO treasury into a token pegged to gold.

For the stablecoin, USDC was chosen over USDT, since it was assessed that the risks of USDC are correlated with risks to the US banking sector and the risks of USDT are those internal to the Tether project. For the staking services, Lido and Aave were chosen for their reputation, with two chosen to reduce protocol risk. For the gold-pegged token, PAXG was chosen as the gold-pegged token with the largest market capitalization.

Description

1. Definition of “treasury management” and “ETH varieties.” For the purpose of this proposal, “treasury management” refers to the movement, storage, and exchange of tokens in the Quantum Biology DAO’s treasury, including swapping one asset class for another. The DAO’s treasury includes all of its holdings at wallet address 0xDF00…FE05. “ETH varieties” refers to Ethererum (ETH), Wrapped Ethereum (WETH), and Staked ETH (stETH).

2. Current DAO treasury. At the time of this proposal, the Quantum Biology DAO has holdings in ETH varieties, USDC, and QBIO. These holdings are, rounded to the nearest hundredth:

• 803.45 ETH varieties — 0.70 ETH — 475.35 stETH — 327.40 WETH
• 1,073,425.57 USDC
• 33,898,949.67 QBIO

This tally does not include BIO tokens which are expected from BIO’s bio/acc rewards program, described in their BIOPSY-5 snapshot proposal, unminted QBIO, or the Quantum Biology DAO’s ETH, SOL, and USDC used to maintain Ethereum and Solana liquidity pools, as described in DAO proposals DP-2 and DP-3, respectively.

3. Previous treasury management plan superseded. The previous treasury management plan, described in DP-17 under the label “Near-Term Treasury Management” is now superseded. Trades and restrictions described in that proposal are no longer in effect, unless they are put into effect by this or a future DAO proposal.

4. Six months runway in USDC. The Quantum Biology DAO shall ensure that it has USDC in its treasury to cover six months’ worth of estimated DAO expenses. For the purposes of this proposal, DAO expenses include both DAO operations and DAO grants. DAO monthly operations are estimated at $10,000, which is 1/12 of the DAO’s Annual Budget, as described in DP-6. DAO monthly grant expenses are estimated at $165,000, as reported by the Quantum Biology Institute (QBI), the DAO’s current grantee.

= Six months’ DAO runway - $1,050,000

(Full table in proposal linked above.)

5. Runway in USDC maintained. The runway described in point 4 shall be periodically replenished by trades of ETH varieties for USDC. This may happen up to monthly and shall not happen less frequently than every three months.

6. USDC is staked using Aave. USDC in the DAO’s treasury shall be staked using Aave. It may be unstaked (1) prior to its being transferred or swapped as otherwise authorized or (2) from concern about protocol risk. If it is unstaked due to concern about protocol risk, this action must be approved by the leader of the Treasury working group or a majority vote among Core Contributors.

7. Five percent into gold via PAXG. The Quantum Biology DAO shall conduct swaps so that 5% of its treasury, excluding USDC in runway (see point 4), QBIO, and BIO, is in PAXG, a gold-pegged token. It is expected that as other DAO assets are sold, the percentage of PAXG in the DAO’s treasury will increase.

8. Remaining financial assets in ETH equivalents. The Quantum Biology DAO shall conduct swaps such that the remainder of its treasury, which is its non-trivial treasury assets other than QBIO, BIO, PAXG, and USDC in runway (see point 4), are in ETH equivalents.

9. ETH is staked, split between Lido and Aave. ETH and WETH in the DAO’s treasury shall be staked, so that 50% are staked using Lido and 50% are staked using Aave; WETH will be swapped for ETH as necessary to permit staking. These tokens may be unstaked (1) in order to be transferred or swapped as otherwise authorized or (2) from concern about protocol risk. If any are unstaked due to protocol risk, this action must be approved by the leader of the Treasury working group or a majority vote among Core Contributors.

10. Timeline for treasury setup. Points 4, 6, 7, 8, and 9 above are part of a one-time setup of the DAO treasury. The swaps necessary to complete the relevant actions should be conducted in a timely manner upon the passage of this proposal.

11. Permitted ETH to USDC trades. The following trades are permitted by the DAO, which means that a DAO proposal does not need to be passed in order for them to be authorized:

• 160 ETH for USDC at the price of $4,000 per ETH
• 160 ETH for USDC at the price of $4,500 per ETH
• 160 ETH for USDC at the price of $5,000 per ETH

12. Triggers for ETH to USDC trades. The ETH-to-USDC trades above (see point 11) are not automatically triggered. Rather, they may be triggered by a two-thirds vote among DAO Core Contributors. If these trades are triggered, they shall be executed promptly when ETH is at or above the relevant prices.

13. Operational details of trades. The operational details of trades, including the time for multi-sig transactions, the number of swaps conducted, whether limit orders are used, and the precise prices for limit orders, are up to the discretion of the leader of the Treasury working group. These details should substantially preserve the intent of the authorized trades.

Example. For instance, if DAO Core Contributors, by a two-thirds vote, trigger a 160 ETH trade for USDC at $4,000, the leader of the Treasury working group may decide to execute the trade by placing five limit orders of 32 ETH each at the prices of $3,800, $3,900, $4,000, $4,100, and $4,200.

14. Management of QBI grant. The Quantum Biology DAO previously made a grant of 500 ETH to QBI (DP-20). 123.01 of that ETH has been dispensed to date, leaving 376.99 ETH in the DAO treasury earmarked for QBI.

Either (1) QBI or (2) Core Contributors of the DAO, by a two-thirds vote, may request that some or all of the ETH earmarked for QBI be converted into USDC earmarked for QBI. To the degree possible, this will be achieved by altering which assets in the DAO’s treasury are earmarked for QBI instead of by swapping ETH for USDC, i.e., by “internal trade.” Any further amount will be converted via an ETH-to-USDC trade, which shall be executed in a timely fashion.

The DAO will retain a record of how much of the ETH and USDC in its treasury is from the grant to QBI, as well as the times of any “internal trades,” i.e., when earmarks are changed as described above. The price of ETH for internal trades will be determined by its reported price on CoinMarketCap.com. The treasury continues to be empowered to transfer monthly QBI funding to QBI from its grant as needed, as specified in DP-20.

15. No impact on other DAO operations. The dispensing of ETH, USDC, or QBIO as part of previously approved DAO operations, including DAO grants, though excluding the provisions of point 3 above, are unaffected by this proposal.

16. Other treasury management actions require DAO approval. Any treasury management actions other than those described above require DAO approval. This does not apply to day-to-day operations of the DAO, which are excluded by point 14 and 15.

Conclusion

The above mid-term treasury management plan will provide a sustainable runway for the DAO even in the event of volatility in the crypto markets while maintaining the substantial upside potential that comes with exposure to ETH. Staking held USDC and ETH with reputed protocols will allow the DAO to earn financial rewards while minimizing risk associated

...

Text truncated: full conclusion in proposal text.